Heart and blood vessel issues in elderly ICU patients
Part of Heart & circulation clinical trials.
This study looks at heart and blood vessel problems in elderly patients who are in the intensive care unit. It aims to better understand and manage these conditions to improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 80 years old or older.
- You must be currently admitted to the intensive care unit (ICU).
- You (or a family member) need to provide consent to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks patients with sudden heart problems admitted to a special heart intensive care unit. It helps doctors learn more about these conditions to improve future care.
This study looks at how frailty (overall weakness and vulnerability) affects recovery, disability, and quality of life in older adults after a serious ICU stay. It aims to understand how pre-existing frailty influences outcomes to improve care for older ICU patients.
This study looks at how family members can be involved in making treatment decisions for older patients (75+) in the ICU. It aims to improve care for very old patients who are expected to stay in the ICU for more than 3 days.
This trial tests a special care program for people with both frailty (being weak or vulnerable) and heart failure (when the heart doesn't pump well). The program brings together different types of support to help you manage your health better after a hospital stay.
This trial looks at ways to help “frailty” (low strength and resilience) in people staying in intensive care units. It mainly enrolls adults who expect to be in the ICU for more than 24 hours, and it tries to avoid people whose mobility problems have other causes.
This study looks at whether frailty (weakness and vulnerability) can help predict the risk of bleeding in older patients who have had a heart attack. The goal is to better identify who might need extra monitoring or different treatments to prevent dangerous bleeding.
Hear when a new Acute Cardiovascular Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.